Company / Free Cash Flow per Share
Tango Therapeutics, Inc. Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.30
FY2025
5-year range
-$1.36 / $1.71
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
#115 of 192
Health Care
What the data says
At $-1.30, Tango Therapeutics, Inc.'s free cash flow per share ranks #115 of 192 in the Health Care sector. Improved from $-1.36 to $-1.30 over the past 2 years.
Based on SEC 10-K filings.
-1.30 in FY2025.
Improved from $-1.36 to $-1.30 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 192 in Health CareTop 60% of 192This company -$1.30 Sector average -$19.84
▼
+93.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 0.4% year-over-year.
- Ranks #115 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.30 | -0.4% |
| FY2024 | -$1.29 | +4.5% |
| FY2023 | -$1.36 | -93.2% |
| FY2022 | -$0.70 | -141.1% |
| FY2021 | $1.71 | -20.9% |
| FY2020 | $2.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026